NeurogesX Company
NeurogesX develops and commercializes therapies for chronic peripheral neuropathic pain.
Technology:
Neuromodulation
Industry:
Genomic and Epigenominc Instabillity
Headquarters:
United States
Founded Date:
1998
Employees Number:
11-50
Funding Status:
N/A
Register and Claim Ownership